Treatment for Alcohol Use Disorder in Medicaid Managed Care

项目总结 随着国家继续努力应对与酒精相关的住院和死亡率上升的问题，扩大对 酒精使用障碍(AUD)治疗仍然是一个紧迫的公共卫生优先事项。虽然医疗补助计划的定位是 成为改善获得抗精神病药治疗机会和降低弱势人群死亡率的关键政策杠杆， 许多州的医疗补助计划并不涵盖AUD治疗和使用的整个连续过程 可能限制访问的管理参数。此外，大多数州的医疗补助计划都与 管理保健组织(MCO)。虽然超过70%的医疗补助参与者参加了MCO计划，但很少有 知道这些计划如何涵盖AUD治疗。为了填补这一科学证据的空白，我们将进行 医疗补助MCO覆盖面和使用管理设计对澳元影响的首次多态研究 治疗收据和结果。这项研究将全面涵盖18个州的142项MCO计划 连续不断的治疗。我们还建议利用创新的随机自动分配方法在两个 州医疗补助计划。我们的具体目标将包括：(1)估计MCO的覆盖范围和 利用管理设计与确定和开发的主要阶段相关 AUD的治疗(诊断、启动、参与和保留)；(2)评估MCO计划的覆盖范围 和使用管理参数与酒精相关的急诊科就诊和 住院；以及(3)评估AUD的识别和治疗阶段的进展情况 与酒精相关的死亡有关。这项拟议的研究将是对 AUD治疗的MCO覆盖范围对治疗收受和结果的影响--缺乏证据 很大一部分澳元人口的护理受到了损害。作为与酒精相关的住院和 死亡率继续上升，关于医疗补助MCO覆盖AUD治疗的影响的证据是 急需之物。这项研究将为决策者提供基于证据的指导，指导他们如何构建 MCO的合同安排，以确保适当和有效地获得AUD治疗。 1

PROJECT SUMMARY As the nation continues to grapple with rising alcohol-related hospitalization and mortality, expanding access to alcohol use disorder (AUD) treatment remains an urgent public health priority. While Medicaid is positioned to be a key policy lever to improve access to AUD treatment and reduce mortality among vulnerable populations, many state Medicaid programs do not cover the full continuum of AUD treatment and use utilization management parameters that may restrict access. Moreover, most state Medicaid programs contract with managed care organizations (MCOs). While over 70% of all Medicaid enrollees participate in MCO plans, little is known about how these plans cover AUD treatment. To fill this gap in the scientific evidence, we will conduct the first multi-state study of the effects of Medicaid MCO coverage and utilization management design on AUD treatment receipt and outcomes. The study will encompass 142 MCO plans, across 18 states, for the full continuum of treatment. We also propose to make use of innovative random auto-assignment methods in two state Medicaid programs. Our specific aims will include: (1) estimating how MCO plans’ coverage and utilization management designs are associated with progression through the major stages of identification and treatment of AUD (diagnosis, initiation, engagement, and retention); (2) estimating how MCO plans’ coverage and utilization management parameters are associated with alcohol-related emergency department visits and hospitalizations; and (3) estimating how progression through the stages of identification and treatment of AUD is associated with alcohol-related mortality. The proposed study will be the first comprehensive investigation of the effects of MCO coverage for AUD treatment on treatment receipt and outcomes – evidence without which the care of a large fraction of the AUD population is compromised. As alcohol-related hospitalization and mortality continue to rise, evidence regarding the impact of Medicaid MCO coverage for AUD treatment is urgently needed. This research will equip policymakers with evidence-based guidance on how to structure MCO contractual arrangements to ensure appropriate and efficient access to AUD treatment. 1